Investigation of the disease process and drug combinations in patients with suspected/confirmed COVID-19 using favipiravir.

Administration of favipiravir later in the course of the disease makes it difficult to achieve the true efficacy expected from the drug and also makes it difficult for other combination drugs to contribute to survival. Favipiravir may also be effective in case of recurrence.